ICON Public Limited (NASDAQ:ICLR – Get Free Report)’s share price reached a new 52-week low on Thursday after Truist Financial lowered their price target on the stock from $284.00 to $262.00. Truist ...

People who ate two servings of this food per week were a fifth less likely to develop Bifidobacterium-positive proximal colon cancer ...

Allogene Therapeutics (ALLO) announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ...

Campaigners say children in study would be ‘treated worse than guinea pigs’ because drugs’ harms are well known ...

While a federal judge has paused the funding cuts, the uncertainty has researchers concerned about the future of scientific ...

The research found that, compared to placebo, weekly injections of semaglutide (also marketed for weight loss as Wegovy) helped reduce cravings in people with alcohol use disorders. The drug also ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Trump’s pause in USAID spending has put major African HIV vaccine and prevention trials on hold, leaving the research world ...

Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology ...

Low total cholesterol levels were tied to an increased risk of death for pulmonary fibrosis patients with disease of unknown ...

Supplementing omega-3 fatty acids, nutrients in fish oil and walnuts, may help slow aging, especially if you exercise and ...

The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle cell disease.